City

Wuhan (1)

Condition

CXCR4 (1)

Hematological Malignancy (1)

PET/CT (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

Sponsor

Zhongnan Hospital (1)

Collaborator

Intervention

68ga-pentixafor (1)

pet/ct (1)

Study Documents

Intervention Type

device (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

cxcr4

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

Not yet recruiting

CXCR4
+2 more

68Ga-pentixafor
PET/CT

Wuhan, Hubei, China

Zhongnan Hospital of Wuhan University

Feb 15, 2022